GlassScriptPhysician profile
Richard Emerson
NPI 1730150061
$802.62
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $304.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $390.34 | 2019-2020 | |
| Zyla Life Sciences, INC. | $164.77 | 2019 | |
| Amgen INC. | $45.15 | 2020 | |
| Pacira Therapeutics, INC. | $44.71 | 2020 | |
| Wright Medical Technology, INC. | $31.25 | 2019 | |
| Electronic Waveform Lab, INC. | $27.30 | 2019-2020 | |
| Medtronic Vascular, INC. | $24.67 | 2019 | |
| Ethicon US, LLC | $16.95 | 2019 | |
| Fidia Pharma USA INC. | $16.80 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.59 | 2020 | |
| Bioventus LLC | $13.90 | 2019 | |
| Orthofix Medical, INC. | $11.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Emerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.